What’s Hot – BXN, ILT, LRV, EXR, LTP, WTM & PSC
What’s Hot, Not & Doing Brought to you by TSN Contributor & Wealth Advisor Nick Kelso What’s Hot – BXN, ILT, LRV, EXR, LTP, WTM & PSC What’s Not – ING What’s Hot BXN – Bioxyne Limited today closed up 71% to finish at 1.2c on $470k stock traded. There was no news out today […]
What’s Hot – FL1, ION, SER, SS1, RDN, VTX, M2R, ERW & LTP
What’s Hot, Not & Doing Brought to you by TSN Contributor & Wealth Advisor Nick Kelso What’s Hot – FL1, ION, SER, SS1, RDN, VTX, M2R, ERW & LTP What’s Not – MP1 What’s Hot FL1 – First Lithium Limited today closed up 65% to finish at 15.5c on $200k stock traded. The reason they […]
HITIQ Limited (ASX:HIQ) secures second US Patent for key part of its Nexus™ technology
HITIQ Limited (ASX:HIQ) has received a second US Patent relating to an innovative design feature for its Nexus™ technology. The US Patent and Trademark Office has issued a Notice of Allowance for HITIQ’s patent application US 17/427,869 “Instrumented mouthguard devices and components configured for use in instrumented mouthguard devices “, meaning that the Company expects […]
AuMEGA Metals (ASX:AAM): Commenced the second phase of diamond drilling on the Cape Ray Shear Zone
AuMEGA Metals (ASX:AAM, TSXV:AUM, OTCQB:AUMMF) has commenced the second phase of diamond drilling on the Cape Ray Shear Zone located in Newfoundland, Canada. 🚜 The primary focus of this diamond drilling is on Greenfield targets at Malachite. ⛏️ Drill targets at Malachite focused on large, mineralised zones identified through the highly successful winter Reverse Circulation […]
GTI Energy Limited (ASX:GTR): Accelerating development of US-based Insitu Recovery uranium resources
GTI Energy (ASX:GTR) is a Wyoming, USA-focused mining company focused on accelerating the development of its flagship Lo Herma ISR uranium deposit. ISR deposits like Lo Herma, which have historically been extracted quickly, cost effectively with a low environmental impact, will give GTI leverage to shifting US uranium demand/supply dynamics. US authorities are now intent […]
Lithium Universe (ASX:LU7): Leverage to rising demand for lithium chemical products
Lithium Universe (ASX:LU7) plans to address the ‘Lithium Conversion Gap’ in North America by developing a process in Canada, to turn mined lithium into battery-grade lithium carbonate. This will allow the company to supply the auto industry with lithium chemicals needed for electric vehicle (EV) batteries. Lithium Universe plans to use”take or pay” contracts with […]
BlinkLab (ASX:BB1): Creating better tests to diagnose various neurodevelopmental conditions
BlinkLab (ASX:BB1) is a digital healthcare company that uses smartphones, computer vision, AI, and machine learning to create a platform for diagnosing neurodevelopmental conditions like autism, ADHD, and schizophrenia. Their most advanced product is an autism diagnostic test for children as young as 18 months old. This test is much better than traditional methods, which […]
EZZ Life Science Holdings (ASX:EZZ) Creating health supplements that meet identified consumer demand
EZZ Life Science Holdings (ASX:EZZ) is a life science company focussed on genomic research and development, addressing four key human health challenges: genetic longevity, human papillomavirus (HPV), children’s care, and weight management. The Company formulates, produces and distributes health supplements under the brand of EZZ, and is also an exclusive distributor of skin care products. […]
FBR Limited (ASX:FBR): Brick laying robot systems developer revolutionising building construction
FBR Limited (ASX:FBR) designs, develops and builds dynamically stabilised robots. These robots are designed to work outdoors and use the Company’s proprietary core Dynamic Stabilisation Technology® platform, or DST® for short. The first application of DST® is Hadrian X®, a bricklaying robot that builds structural walls faster, safer, more accurately and with less wastage than […]
PharmAust Limited (ASX:PAA): Developing new treatments for neurodegenerative diseases
PharmAust ASX:PAA) is a clinical-stage biotechnology company developing therapeutics for neurodegenerative diseases. The company is focused on repurposing monepantel for amyotrophic lateral sclerosis, the most common form of motor neurone disease. It has recently realised significant milestones in the development of monepantel for this sclerosis. These achievements include a recent study that could potentially lead […]